Trending News
News
News
The Conference Forum Announces the Launch of the 2nd Annual Medicaid Rebate Summit
Summit will address the interpretation of the anticipated Final Rule and the larger implications of Medicaid expansion.
News
ISPE Names Dr. Thomas Zimmer as Vice President of European Operations
Dr. Zimmer will be responsible for leading ISPE’s business development and advancing strategic relationships in Europe.
News
Neuroptis Biotech Announces the Preclinical Results for its Dry Eye Product ML7
Human clinical trials are planned for mid 2014.
News
Gyros Immunoassay Platform Selected by BioAgilytix Labs to Support Bioanalysis Services
Gyros AB announced that BioAgilytix Labs has invested in two Gyrolab™ xP workstations to support its bioanalysis services.
News
AstraZeneca to Invest £120 Million in New Manufacturing Facility
AstraZeneca invests to continue production of Zoladex, an injectable treatment for patients with prostate cancer.
News
Promethera Successfully Enrolls Twenty Patients in its Multicentric Phase I/II Trial
Promethera Biosciences has conducted the trial in Belgium, France, United Kingdom, Italy and Israel, treating twenty patients affected by very rare liver-based metabolic diseases.
News
BioFocus Signs Agreement with Biogen Idec
The 3-year collaboration will focus on the identification and validation of novel targets in scleroderma.
News
Karus Therapeutics Appoints Penelope Ward as CMO
Dr Ward will drive Company’s HDAC6 and PI3K inhibitor programmes.
News
Designer Piercings: New Membrane Pores with DNA Nanotechnology
A new way to build membrane-crossing pores, using Lego-like DNA building blocks, has been developed by scientists.
News
Alnylam Reports Positive Phase II Data for Patisiran (ALN-TTR02)
New results in ATTR patients show up to 96% knockdown of TTR with activity toward both wild-type and mutant TTR.
Advertisement
